Towards fully automated segmentation of rat cardiac MRI by leveraging deep learning frameworks

Daniel Fernández-Llaneza1, Andrea Gondová2, Harris Vince2

  • 1Clinical Pharmacology and Safety Sciences, Biopharmaceuticals R&D, AstraZeneca, Pepparedsleden 1, 431 83, Mölndal, SE, Sweden. daniel.fernandez1@astrazeneca.com.

Scientific Reports
|June 2, 2022
PubMed

Related Concept Videos